Stanford University
Stanford, California, 94305, United States
NCT Number: NCT03182075
Obsessive-Compulsive Disorder (OCD) is a chronic and disabling disorder that costs the economy over $2 billion annually and represents a significant public health problem. This study aims to build on our understanding of aberrant emotional processing in OCD. The proposed project tests whether a computerized training aimed to alter emotional processes, can relieve repetitive thoughts and behaviors.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
OCD and hoarding disorder participants will receive 14 sessions of training via computer within 3 weeks.
Time frame: up to 2 months
Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.
Time frame: up to 2 months
The SI-R is a 23-item questionnaire with 3 factor-analytically defined sub-scales for difficulty discarding, excessive clutter, and compulsive acquisition.
Stanford University
Other
Emotional Reactivity Training for Obsessive-Compulsive and Related Disorders
Acronym: EmRT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001548
Anxiety Disorders, Basal Ganglia Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00035438
Anxiety Disorders, Behavior
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT00004324
Anxiety Disorders, Basal Ganglia Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT00004325
Anxiety Disorders, Basal Ganglia Diseases
New Haven, Connecticut, United States
View Trial Details